1-2 of 2
David B. Lieberman, MS, CGC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline POT1 Variants Can Predispose to a Variety of Hematologic Neoplasms

Free
Tristan L. Lim, BSc, David B. Lieberman, MS, CGC, Adam R. Davis, MD, Ryan Hausler, MS, Ashkan Bigdeli, MS, Yimei Li, PhD, Jacquelyn Powers, MS, LCGC, Regeneron Genetics Center, Shannon A. Carty, MD, Katherine L. Nathanson, MD, Adam Bagg, MD, Elizabeth O. Hexner, MD MSTR, Kara N. Maxwell, MD PhD, Jennifer J.D. Morrissette, PhD, Daria V. Babushok, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
https://doi.org/10.1182/blood-2020-134160
Published: 2020
Journal Articles

Mechanisms of Acquired Resistance to Gilteritinib Therapy in Relapsed and Refractory FLT3 -Mutated Acute Myeloid Leukemia

Free
Christine M. McMahon, MD, Jonathan Canaani, MD, Bryan Rea, MD, Rachel Lynn Sargent, MD, Jennifer J.D. Morrissette, PhD, David B. Lieberman, MS, CGC, Christopher Watt, MD PhD, Gregory W. Schwartz, PhD, Robert B. Faryabi, PhD, Timothy T. Ferng, MD, Neil P. Shah, MD PhD, Catherine C. Smith, MD, Martin Carroll, MD, Alexander E. Perl, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 295.
https://doi.org/10.1182/blood.V130.Suppl_1.295.295
Published: 2017